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Abstract A human MT gene from the functional locus on 
chromosome 16, MTIL, is characterised and shown to produce 
mRNA in at least four human tissues. This gene is unlikely to 
produce a metallothionem protein because it contains a termina-
tion codon at position 26, by analogy to other human MT1 genes. 
MTIL cDNA is almost identical to another metallothionem 
cDNA clone reported recently, MT1R, suggesting that either 
there are unmapped human metallothionem genes, or that MTIL 
is polymorphic. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Metallothioneins are small cysteine-rich proteins which in 
humans are encoded by a multigene family on chromosome 16 
[1]. The MT2A gene, and 13 MT1 isogenes have been linked 
to one cluster [2], whilst evidence suggests that the MT3 and 
MT4 genes are located nearby [3]. Much work has been de-
voted to establishing which of these genes are functional, and 
the proteins encoded by MT2A, MT3, and the MT1 isogenes 
MT1E, MT1H (also known as M T O , [4]) and MT1X have 
been isolated from human tissues [5,6], although additionally, 
specific m R N A transcripts have been identified in human tis-
sues from MT1F and MT1G ([7], unpublished data). U p to six 
isoforms of M T have been isolated from human liver by 
H P L C [5], and it is likely that additional separation tech-
niques such as capillary electrophoresis [8] will allow a further 
estimate of how many isoforms are actually present at the 
protein level. The physiological need for multiple MT1 or 
2 isoforms in the human, and in most other mammals studied, 
is not yet known. 
Recently, a P C R product of the c D N A from a novel MT1 
isogene was cloned from human reticulocytes using a PCR 
approach [9] and determined to be unique on the basis of 
its nucleotide sequence. We show here that this cDNA, called 
MTIR, is almost identical to the product of the MTIL gene on 
chromosome 16 suggesting that either this gene is polymor-
phic, or that there are further uncharacterised MT1 genes in 
the genome. MTIL is expressed at the m R N A level in a num-
ber of human tissues, but contains an in-frame termination 
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codon at amino acid position 26 which would prevent pro-
duction of a typical M T protein2 . 
2. Materials and methods 
2.1. Hybridisation analysis 
RNA was isolated and subjected to northern analysis as described 
previously [11]. Probes were 5' radiolabelled with [y-32P]ATP and 
hybridised to filters in 20% formamide buffer at 42°C for 16 h. Filters 
were washed up to a stringency of 0.2XSSC, 1% SDS at 45°C and 
then exposed to autoradiography film (Amersham). The following 
oligonucleotides were used as probes: 
MTIL 5 ' - A A A T G A C G G G A G A G G C G A - 3 ' : 
MT2A 5 ' - A T C C A G G T T T G T G G A A G T C G - 3 ' : 
MT1G 5 ' - G G T C A C T C T A T T T G T A C T T G G - 3 ' : 
MT1H 5 ' - C G T G T C A T T C T G T T T T C A T C T G A C - 3 ' : 
MT1X 5 ' - G C T C T A T T T A C A T C T G A G A G C A C A - 3 ' : 
P-actin 5' - C A C A C T T C A T G A T G G A G T T G A - 3 ' 
The MT oligonucleotides were demonstrated to be gene specific 
using a cosmid blot containing cosmid clones which covered the 
MT1/2 locus on chromosome 16 as described previously [10]. The 
(3-actin oligonucleotide was used to validate the amount of mRNA 
loaded in each lane of the northern blot. 
2.2. RT-PCR 
RT-PCR was performed by a modification of the method outlined 
previously [12]. Briefly, RNA (1 ug) was reverse transcribed in 20 ul 
reaction buffer containing: 50 mM Tris-HCl, pH 8.3, 75 mM KC1, 
3 mM MgCl2, 10 mM DTT, 0.5 mM of each dNTP, 10 ug/ml 
oligodTi6, 20 units RNasin, 200 units M-MLV reverse transcriptase 
for 1 h at 37°C and then diluted to 200 ul with sterile water. PCR was 
in a 50 ul reaction containing: 10 mM Tris-HCl, 1.5 mM MgCl2, 50 
mM KC1, 250 uM of each dNTP, 0.4 uM of each primer, 2.5 units 
Taq polymerase (Boehringer-Mannheim) and 4 ul of the reverse tran-
scription reaction or 10 ng of plasmid DNA. PCR was for 35 cycles 
with a cycle sequence of 95°C for 1 min, 60°C for 1 min, 72°C for 
1 min. The following PCR primers were used: MTIL sense (5'-
TCGCCTCTCCCGTCATTT-3') and antisense (5'-AGCAGGGCT-
GTCCCCA-3'). 
PCR reactions were electrophoresed through 1.4% agarose/1 XTBE 
and visualised by ethidium bromide staining. PCR products were 
excised from the agarose gels, recovered by centrifugation through 
glass wool, blunt-ended with mung bean nuclease (Promega) and li-
gated in pUC19. 
2.3. Nucleotide sequencing 
Clones were purified from Escherichia coli and sequenced using 
Sequenase version 2 (USB). Resulting fragments labelled by the in-
corporation of [3oS]dATP were electrophoresed through 6% polyacryl-
amide gradient gels and detected by autoradiography. Alternatively, 
clones were purified using the QIAGEN Plasmid mini kit and se-
quenced using the ABI PRISM Dye primer or Dye terminator Cycle 
2 A preliminary report on the deduced amino acid sequence encoded 
by MTIL has been presented in [10]. The complete nucleotide se-
quence of MTIL has been submitted to GENBANK. 
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ACAAGAAATGGGAATATGGGAAGTTCGCGCGGACGGCACGGCACCGCGGGACGACCGGGCGCACAGGCCTGAGCGAGCGAGCGAGTGAGCGGGTGCCAAG 
101 . . . . . . . . . 200 
CAAGAGACCCGCGGTGCACACCTTGCGCCCGGCCCGCCTGCTGCTCACAGTCCCTCCACGTACCCACAGGAGGCCCAGACTCAGCGGGGCGGGTGCAAGC 
201 . . . . PruII . . PruII . 300 
GCGGGGCGGGGCCTCTGCGTCCGGTCCCATCTCCGCCTGCAAAAGGAGCAGCTGGCTCCAGGCTCCAA^ 
301 . . . . . . . . . 400 
CCTC^CCCGTCATTTCTTGGgTCGAAATGGACCCCAACTGCTCCTGCGCCACrGGTAAGGGAACCCCGGCTCTGCGCgrGGGAATGCCCAATTCCCAGCC 
MetAspProAsnCysSerCysAlaThrG 
401 . S a d . . . . . 500 
AI^^TACAGTGTCCCTGCGTTTGAGGAGGTCGCATTTTGAGCTCTGAGCAGtAAGGGA^ 
501 . . . . . . . . . 600 
AGAGC^TTGCCCTCCTCACTGTGCCTCTATGTCAGAGTTGAGTGTCCTGAGGCrrCAAGGCTGTCCTG 
601 . . . . . . . . . 700 
GCCAAGCCCCAATGCTCTGTCTAGGCTCTAAGCAAGCAGGGTGGGTGGGAGGCAGGGA 
701 . . . . . . . . . 800 
TCCCAGTCCTCCTGTGTTGTGTGTGTATCTGGGACCTTCCTGGTGGGGTGAAATAGGAGGGTGCTTGCCCTTCCCAGCACGAGTGGAGAGGACATGGGGC 
801 . . S a d . . . . . . 900 
TTGTCTTTCTCTGCTCTAAGTGGGAAAGGAGCTC^GAGGGgrGGCCCTGCACAGAGGATGGCGCACACTGGAGACTCATTGACCCACTGCTGTACCTTCT 
901 . . . . . . . . . 1000 
TCCTCTCACTCACTTGCCCAI^GCGTTTTTCTCTTCCTTGCAGGGGGCrCCTGCTCCTGTGCCAGCTCCTGCTVAGTGCAAAGAGTGCAAATGAACCTCCT 
lyGlySerCysSerCysAlaSerSerCysLysCysLysGluCysLys * ThrSerC 
1001 . . . . . . . . . 1100 
GCAAGAAGAGTGAGTGCGGGGCCATCTCCAGGAATCTGGGGCTGTGGCTAAGGTTGGGAGGGAACTCAAGGCTGGCCTGGAGTGCATGCTCTGGGGAACG 
ysLysLysS 
1101 . . . . . Sael . . . . 1200 
CTTTCTTTGCCCCTGTTGGCCATGTCATTCCCTCTCCAGGCTTTCTGCTCTGAGCTCGAATGTGGCAGGGCAGCCTTTTTCTTTTGAGACACAAACTCCA 
1201 . . . . . . . S a d . . 1300 
AAGGTACCACCTGCGGTCTTAGAACAGAGCTGTACTAACCTAAAAAATCATCCTCTGGGTCTGGAGTCTGAGCTCGAACCAGGCCTGCTGTTGGGCCAGG 
1301 . . . . . . Ncol . 1400 
GAAGTGCCTGATTGAGTCCGCTCTGACCTCTCACTCTCCCTTTTCCCCCAGGCTGCTGCTCCTGCTGCCCCATGGGCTGTGCCAAGTGTGCCCAGGGCTG 
erCysCysSerCysCysProMetGlyCysAlaLysCysAlaGlnGlyCy 
1401 . . PruII . . . . . . 1500 
CGTCTGCAAAGGGGCGTCGGAGAAGTG(^GCTGCTGTGCCTGATGTGGGGACAGCCCTGCTCCCAGATGTAAACAGAGCAACCTGCACAAACCTGGATTT 
sValCysLysGlyAlaSerGluLysCysSerCysCysAlaTer 
1501 . . . . . . . . . 1600 
TTTTTTCATAGAACCCTGAGCGTTTGCTACATTCCTTTTTCTATTAAATATGTAAACGACAATAAAACAGTTTTGACTTGATTCGGACCCTCCTTTCCTT 
1601 . . . . . . . . . 1700 
TGTGTGGCTTTGAATTAATGGACCAGGGTTAGGGATTGAACCTGGAGTTTAGAGACCCAGGCTCTGGATGGACATGTGAGTCGCTAACAATCTGAGCGCC 
1701 . . . . . . . . . 1800 
TCCTGACAAGCCAGGTTACCTCACTGAGCTTCATCTTCTATAAAAGGGAATTGCACTGTGCCAGGTCATAATGGGGGGACATCTATGATCACCTCTGGTC 
1801 . . . . . . . 1900 
ATATCAATTGTGGCACAGAAACTTCTCCATCTCTCGTTTTTATTTTCTGATTTCCCTGCCCAATTTCAGTTTCCTCTTCAGATTTTAGGCTTCAAAGAGA 
1901 . . PruII 
TGACAGGGGTGGAATCCAATTCCTCAGCTG 
Fig. 1. Nucleotide sequence of the human MTIL gene. The putative amino acid sequence is indicated below the coding regions. Recognition 
sites for the restriction endonucleases Ncol, SacI and PvwII are indicated. Binding sites for oligonucleotides designed to amplify the gene or 
cDNA by PCR are shown (double underlined). 
Sequencing Reaction Kit (Perkin Elmer Cetus) and the ABI PRISM s h o w n w a s derived from ?i39-2, whilst the coding regions of 
377 DNA Sequencer (Perkin Elmer Cetus). ,, c , c t i,^ ., ~ , , . - . 
y the gene were confirmed from chMT-51. On the basis of the 
predicted amino acid sequence (by analogy to other mamma-
3. Results lian MT proteins), this gene encodes a MT1 isoform, however, 
it contains an in-frame termination codon at a position equiv-
The nucleotide sequence of the human MT gene, MTIL, is alent to amino acid 26 (see Fig. 1). On the basis of this se-
shown in Fig. 1. This sequence was derived from subclones of quence, PCR primers were designed which were shown, using 
two unrelated genomic clones, a bacteriophage lambda clone cosmid clones of the MT1/2 locus on chromosome 16 [2] to 
X39-2 [13] and a cosmid clone chMT-51 [2]. The sequence as only amplify MTIL (data not shown). mRNA isolated from 
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human pancreas was reverse transcribed and the resultant 
cDNA used in PCR with the MTIL primers. A fragment of 
128 nucleotides was cloned into pUC19 and sequenced. This 
fragment was identical in sequence to the cognate exons of the 
MTIL gene (shown in Fig. 1) and can be concluded to be an 
authentic cDNA clone from this gene. Note that the smaller 
size of the fragment compared to the predicted product using 
these PCR primers (i.e. 230 bp) is due to the exonuclease 
activity of mung bean nuclease, used to prepare blunt ends 
on the PCR product in preparation for cloning. Importantly, 
this independent clone confirmed that the termination codon 
at position 26 was also present in the mRNA derived from 
this gene. 
The expression of MTIL was examined in a panel of hu-
man tissues using RT-PCR as described above, and by north-
ern blotting using an oligonucleotide confirmed to hybridise 
specifically to MTIL (Fig. 1). As indicated in Table 1, a PCR 
product of the correct size (230 bp) was observed using MTIL 
primers in several tissues, including pancreas, thyroid gland, 
pineal gland and hypothalamus. MT2A was detected by RT-
PCR using specific primers in all tissues examined. 
RNA was isolated from three human thyroid glands and 
analysed by northern blotting using oligonucleotides specific 
for human MT genes. MT2A mRNA was detected in all three 
samples, whilst MTIL mRNA was detected in two of the 
three samples (Fig. 2). In addition, MT1G, MT1H (also 
known as MTO [4]) and MT1X mRNAs were observed in 
at least one of the samples (Fig. 2) whilst MT1A, MT1B, 
MT1E and MT1F mRNA were not detected (data not 
shown). 
4. Discussion 
Fig. 2. Expression of MT mRNA in the human thyroid. RNA was 
isolated from 3 human thyroids (lanes 1-3) and the expression of 
various human MT-I and -II isogenes was examined by northern 
analysis. Gene specific oligonucleotides were used to examine the ex-
pression of the individual MT isogenes. A human P-actin oligonu-
cleotide was used to confirm that equal amounts of RNA were 
present in each lane. 
We describe the complete nucleotide sequence of the human 
MT1 gene MTIL, and show that this gene produces a mRNA 
which is present in at least four human tissues. However, the 
predicted amino acid sequence of this gene is interrupted by a 
termination codon at position 26, which suggests that it is 
unlikely to produce a functional MT protein. There are how-
ever two other formal possibilities. One is that MTIL produ-
ces a truncated MT protein of 25 amino acids. MTs consist of 
two functionally separated domains which are capable of 
binding metals when experimentally separated, and the pre-
dicted product of MTIL corresponds to an almost complete 
p-domain. It is possible that such a protein would be capable 
of binding group II heavy metals, the hallmark of MTs. No 
Table 1 
Amplification of MTIL and MT2A cDNA by PCR 
Tissue MTIL MT2A 
Liver -
Small intestine -
Large intestine -
Pancreas + 
Thyroid + 
Spleen -
Heart 
Thymus -
Pineal gland + 
Hypothalamus + 
RNA was isolated from human tissues and subjected to RT-PCR 
using primers specific for the human MTIL and MT2A genes. The 
tissues in which specific products from the two genes were (+) and 
were not (-) amplified are indicated. 
such truncated isoform of MT has been identified to date, 
although if expressed at low levels, it may be difficult to detect 
using standard methods. 
Alternatively, MTIL could encode a selenoprotein, since a 
TGA codon has been shown, in a small class of proteins, to 
specify a selenocysteine residue (reviewed in [14]). We feel that 
MTIL is not a promising candidate for a selenocysteine-MT, 
since this gene does not contain many of the consensus fea-
tures exhibited by some (but not all) selenoproteins. For ex-
ample, the 3'UTR of the mRNA encoding the selenoproteins 
glutathione peroxidase and iodothyronine deiodinase contain 
several conserved 3^1 nucleotide sequences and the 3'UTR is 
predicted to form a highly conserved stem-loop structure [15-
17]. These features appear necessary for the incorporation of a 
selenocysteine residue and do not appear to be present in the 
relevant region of MTIL. Nonetheless, it is intriguing to spec-
ulate on the altered properties that inclusion of a selenocys-
teine residue would impart on a metallothionein, and it has 
been observed that relatively low molecular weight, uncharac-
terised selenoproteins are present in the human thyroid (J. 
Arthur, personal communication). 
Recently, it has been reported that a clone encoding a novel 
isoform of MT, MTIR was isolated from human reticulocytes 
[9]. Fig. 3 shows a comparison of the nucleotide sequences 
between the predicted cDNA of MTIL, and the cDNA of 
MTI-R. It is apparent that these sequences are virtually iden-
tical, with the obvious major discrepancy being the TGA ter-
mination codon at position 26. We have confirmed the nucleo-
tide sequence in this vicinity in two independent genomic 
44 A.F. Holloway et al.lFEBS Letters 404 (1997) 41-44 
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MetAspProAsnCysSerCysAlaThrGlyGlySerCysSerCysAlaSerSerCysLys 
ATGGACCCCAACTGCTCCTGCGCCACTGGGGGCTCCTGCTCCTGTGCCAGCTCCTGCAAG 
G 
61 
CysLysGluCysLys * ThrSerCysLysLysSerCysCysSerCysCysProMetGly 
TGCAAAGAGTGCAAATGAACCTCCTGCAAGAAGAGCTGCTGCTCCTGCTGCCCCATGGGC 
T 
CysAlaLysCysAlaGlnGlyCysValCysLysGlyAlaSerGluLysCysSerCysCys 
TGTGCCAAGTGTGCCCAGGGCTGCGTCTGCAAAGGGGCGTCGGAGAAGTGCAGCTGCTGT 
181 
AlaTer 
GCCTGATGTGGGGACAGCCCTGCTCCCAGATGTAAACAGAGCAACCTGCACAAACCTGGA 
A 
241 
TTTTTTTTTCA-TACAACCCTGAGCG-TTTGCTACATTCCTTTTTCTATTAAATATGTAA 
— A.- A.T C 
301 
ACGACAATAAAACAGTTTTGACTTGATTCGGACCCTCCTT 
. . C . - - -....- G-
Fig. 3. Comparison of the MT1L and M77R nucleotide sequences. 
The nucleotide sequence of the predicted MT1L cDNA is shown 
with the predicted amino acid sequence (three letter code) above. 
Mismatches with the M77R cDNA nucleotide sequence are shown 
below. Dots indicate where the Af77R sequence is identical to the 
MT1L sequence. 
clones and one c D N A clone derived from the pancreas. Of the 
14 genes in the linked locus on chromosome 16 only the gene 
designated MT1L [2] could have given rise to the sequence 
reported here, based on P C R using genomic clones spanning 
the whole locus. However, it is possible that the M 7 7 R c D N A 
is derived from a presently uncharacterised gene which is dis-
tinct from MT1L. In light of the recent discovery of at least 
two important but hitherto unsuspected isogenes of MT, MT3 
and MT4 [18,19], this is a plausible explanation, although the 
apparent similarities between MT1L and MTIYL are much 
greater than between any other pair of human M T genes 
yet characterised. 
Alternatively, given the apparent similarities between the 
2 sequences, it is possible that the putative gene encoding 
A / 7 7 R is a polymorphic form of MT1L. We have, however, 
confirmed the sequence of this gene (or its cDNA) from three 
individual people. Analysis of the nucleotide sequence of the 
MT1L gene from a larger number of individuals is necessary 
to resolve this point. 
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